Clinical Evidence

Vendor-neutral deep learning reconstruction of dynamic contrast-enhanced prostate MRI: image quality improvement and preservation of diagnostic performance

Study of 173 patients showing improved image noise, capsule sharpness, and lesion conspicuity on dynamic contrast-enhanced prostate MRI, while preserving PI-RADS-based diagnostic performance for clinically significant prostate cancer (AUC unchanged; one reader’s sensitivity for PI-RADS ≥4 lesions rising from 75.4% to 88.5%).

Lee YJ, et al.. Eur J Radiol. 2026;203:113020. PMID: 42322720.